Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
6.50
+0.12 (1.88%)
Nov 20, 2024, 4:00 PM EST - Market closed

Acrivon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
202109241--
Market Cap Growth
2.74%-54.61%---
Enterprise Value
19-28291--
Last Close Price
6.504.9211.52--
PB Ratio
1.030.901.41--
P/TBV Ratio
1.100.901.41--
Debt / Equity Ratio
0.020.040.030.060.04
Quick Ratio
12.659.5819.6134.182.58
Current Ratio
12.759.7520.2734.462.80
Return on Equity (ROE)
-45.95%-41.41%-23.16%-32.39%-
Return on Assets (ROA)
-29.15%-26.25%-14.18%-18.60%-
Return on Capital (ROIC)
-31.04%-27.84%-14.59%-19.09%-
Earnings Yield
-38.03%-55.30%-12.95%--
FCF Yield
-31.51%-40.23%-13.42%--
Buyback Yield / Dilution
-54.55%-435.63%-136.43%-21.70%-
Total Shareholder Return
-54.55%-435.63%-136.43%-21.70%-
Source: S&P Capital IQ. Standard template. Financial Sources.